Multiple Sclerosis Panel 1 Test
The Multiple Sclerosis Panel 1 test is a diagnostic tool used to help identify and monitor multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. This panel includes several tests that can provide valuable information about the presence and progression of MS.
Test Components
- IgG Synthesis Index & Rate
- Oligoclonal Bands, CSF & Serum
Test Cost
AED 1520.0
Sample Condition
4 mL (3 mL min.) CSF in a sterile screw capped container AND 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated. DO NOT FREEZE. Ideally serum & CSF should be tested simultaneously. Strictly adhere to CSF specimen volumes.
Report Delivery
Sample daily by 9 am; Report next day
Method
BCG, Isoelectric focusing, Immunoturbidimetry, Nephelometry
Test Type
Multiple Sclerosis
Doctor
Neurologist
Test Department
Neurology
Pre Test Information
Ideally serum & CSF should be tested simultaneously. Strictly adhere to CSF specimen volumes.
Test Details
The Multiple Sclerosis Panel 1 test is a diagnostic tool used to help identify and monitor multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. This panel includes several tests that can provide valuable information about the presence and progression of MS. The tests included in the Multiple Sclerosis Panel 1 may vary depending on the laboratory or healthcare provider, but commonly include:
- Magnetic Resonance Imaging (MRI): This imaging test uses powerful magnets and radio waves to create detailed images of the brain and spinal cord. MRI can help identify the presence of MS lesions or plaques, which are characteristic of the disease.
- Cerebrospinal Fluid (CSF) Analysis: A sample of cerebrospinal fluid, which surrounds the brain and spinal cord, is collected through a lumbar puncture. CSF analysis can detect abnormalities such as an increased number of white blood cells or the presence of specific proteins (oligoclonal bands) that indicate inflammation in the central nervous system.
- Visual Evoked Potential (VEP) Test: This test measures the electrical activity of the visual system in response to visual stimuli. It can help assess the integrity of the optic nerves, which are commonly affected in MS.
- Blood Tests: Various blood tests may be included in the panel to rule out other conditions that can mimic MS symptoms, such as Lyme disease or vitamin deficiencies. Blood tests can also measure certain antibodies or proteins that may be associated with MS.
- Neurological Examination: A comprehensive neurological examination is usually performed by a healthcare professional to assess motor, sensory, and cognitive functions. This examination can help identify any neurological deficits or abnormalities that may be indicative of MS.
The Multiple Sclerosis Panel 1 test is typically ordered by a neurologist or other healthcare provider specialized in MS diagnosis and management. It is important to note that this panel is not a definitive diagnostic tool for MS, but rather a combination of tests used to evaluate and monitor the disease. A positive result from the panel, along with a patient’s medical history and clinical symptoms, can aid in confirming a diagnosis of multiple sclerosis.
Test Name | MULTIPLE SCLEROSIS PANEL 1 Test |
---|---|
Components | *IgG Synthesis Index & Rate*Oligoclonal Bands, CSF & Serum |
Price | 1520.0 AED |
Sample Condition | 4 mL (3 mL min.) CSF in a sterile screw capped container AND 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated. DO NOT FREEZE. Ideally serum & CSF should be tested simultaneously. Strictly adhere to CSF specimen volumes. |
Report Delivery | Sample Daily by 9 am; Report Next day |
Method | BCG, Isoelectric focusing,Immunoturbidimetry, Nephelometry |
Test type | Multiple Sclerosis |
Doctor | Neurologist |
Test Department: | |
Pre Test Information | Ideally serum & CSF should be tested simultaneously. Strictly adhere to CSF specimen volumes. |
Test Details |
The Multiple Sclerosis Panel 1 test is a diagnostic tool used to help identify and monitor multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. This panel includes several tests that can provide valuable information about the presence and progression of MS. The tests included in the Multiple Sclerosis Panel 1 may vary depending on the laboratory or healthcare provider, but commonly include: 1. Magnetic Resonance Imaging (MRI): This imaging test uses powerful magnets and radio waves to create detailed images of the brain and spinal cord. MRI can help identify the presence of MS lesions or plaques, which are characteristic of the disease. 2. Cerebrospinal Fluid (CSF) Analysis: A sample of cerebrospinal fluid, which surrounds the brain and spinal cord, is collected through a lumbar puncture. CSF analysis can detect abnormalities such as an increased number of white blood cells or the presence of specific proteins (oligoclonal bands) that indicate inflammation in the central nervous system. 3. Visual Evoked Potential (VEP) Test: This test measures the electrical activity of the visual system in response to visual stimuli. It can help assess the integrity of the optic nerves, which are commonly affected in MS. 4. Blood Tests: Various blood tests may be included in the panel to rule out other conditions that can mimic MS symptoms, such as Lyme disease or vitamin deficiencies. Blood tests can also measure certain antibodies or proteins that may be associated with MS. 5. Neurological Examination: A comprehensive neurological examination is usually performed by a healthcare professional to assess motor, sensory, and cognitive functions. This examination can help identify any neurological deficits or abnormalities that may be indicative of MS. The Multiple Sclerosis Panel 1 test is typically ordered by a neurologist or other healthcare provider specialized in MS diagnosis and management. It is important to note that this panel is not a definitive diagnostic tool for MS, but rather a combination of tests used to evaluate and monitor the disease. A positive result from the panel, along with a patient’s medical history and clinical symptoms, can aid in confirming a diagnosis of multiple sclerosis. |